|
Orozco-Beltran D, Mata-Cases M, Artola-Menendez S, Alvarez-Guisasola F, Cebrian-Cuenca AM, Perez A; DIAMOND2 Study Coordinating Group. On behalf of the study investigators. Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care. Prim Care Diabetes. 2025 Feb;19(1):7-14. doi: 10.1016/j.pcd.2024.12.002. Epub 2024 Dec 31. PubMed PMID: 39741072.
AÑO: 2025; IF: 2.6
|
39741072
|
Cebrian Cuenca AM, Escalada J. [Prevalence of obesity and diabetes in Spain. Evolution in the last 10 years]. Aten Primaria. 2025 Mar;57(3):102992. doi: 10.1016/j.aprim.2024.102992. Epub 2024 Sep 25. Spanish. PubMed PMID: 39326172; PubMed Central PMCID: PMC11459898.
AÑO: 2025; IF: 1.8
|
|
Navarro Gonzalez JF, Ortiz A, Cebrian Cuenca A, Moreno Baron M, Segu L, Pimentel B, Aranda U, Lopez-Chicheri B, Capel M, Pomares Mallol E, Caudron C, Garcia Sanchez JJ, Alcazar Arroyo R. Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project. Nefrologia (Engl Ed). 2024 Nov-Dec;44(6):807-817. doi: 10.1016/j.nefroe.2024.11.009. Epub 2024 Dec 3. PubMed PMID: 39632193.
AÑO: 2024
|
|
Cebrian-Cuenca AM, Moreno-Perez O, Campuzano-Ruiz R, Soler MJ, Garcia de Lucas MD, Orozco-Beltran D. Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study. Arch Med Res. 2024 Jan;55(1):102923. doi: 10.1016/j.arcmed.2023.102923. Epub 2023 Dec 22. PubMed PMID: 38141271.
AÑO: 2024; IF: 4.7
|
|
Orozco-Beltran D, Brotons-Cuixart C, Banegas JR, Gil-Guillen VF, Cebrian-Cuenca AM, Martin-Rioboo E, Jorda-Baldo A, Vicuna J, Navarro-Perez J. [Cardiovascular preventive recommendations. PAPPS 2024 thematic updates]. Aten Primaria. 2024 Nov;56 Suppl 1(Suppl 1):103123. doi: 10.1016/j.aprim.2024.103123. Spanish. PubMed PMID: 39613355; PubMed Central PMCID: PMC11705607.
AÑO: 2024; IF: 1.8
|